Daniel Canade

Daniel Canade currently serves as the Associate Director of Quality at Stemline Therapeutics since November 2022. Prior to this role, Daniel held the position of VP of Regulatory and Compliance at Rochem International Inc. for a brief period in October 2022. Daniel's extensive experience in quality assurance includes managerial roles at The Nature's Bounty Co. and Fougera Pharmaceuticals Inc., as well as a specialist position at Nastech Pharmaceutical. Daniel began a career in quality assurance as a supervisor and microbiologist at American Regent, Inc. Daniel possesses a Bachelor's Degree in Biology and has pursued education at Dowling College, Stony Brook University, and Clarkson University.